Cuize Medicine Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.59M

  • Investors
  • 3

Cuize Medicine General Information

Description

Developer of pulmonary therapy medication intended to be used for the perioperative period. The company developed a sustained release technology platform and inhalation powder technology platform, enabling to reduce side effects and delivers sustained curative effects without burst release phenomenon to pulmonary patients.

Contact Information

Formerly Known As
Zhejiang Xianju Cuize Pharmaceutical Technology Co., Ltd., XianJuCuiZe, XJ Pharma
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 3A03, Building 2, No. 339
  • No. 25 Road, Baiyang Street, Hangzhou Economic and Technological Development Zone
  • Hangzhou, Zhejiang 310000
  • China
+86 0571
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Room 3A03, Building 2, No. 339
  • No. 25 Road, Baiyang Street, Hangzhou Economic and Technological Development Zone
  • Hangzhou, Zhejiang 310000
  • China
+86 0571

Cuize Medicine Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cuize Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 26-Jun-2025 $4.59M Completed Generating Revenue
4. Later Stage VC 29-Sep-2024 Completed Generating Revenue
3. Early Stage VC 11-May-2023 Completed Generating Revenue
2. Secondary Transaction - Open Market 25-Aug-2022 $443K Completed Generating Revenue
1. Joint Venture 08-Jul-2019 Completed Generating Revenue
To view Cuize Medicine’s complete valuation and funding history, request access »

Cuize Medicine Patents

Cuize Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260232646-A1 Method for treating postoperative pain and use thereof Pending 11-Feb-2025
WO-2026171186-A1 Method for treating postoperative pain and use thereof Pending 11-Feb-2025
WO-2026171186-A9 Method for treating postoperative pain and use thereof Pending 11-Feb-2025
WO-2026171187-A1 Stable crystal of ropivacaine Pending 11-Feb-2025
US-20260234109-A1 Stable ropivacaine crystals Pending 11-Feb-2025 C07D211/60
To view Cuize Medicine’s complete patent history, request access »

Cuize Medicine Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jiangguo Investment Management Venture Capital Minority
Goldport Capital Venture Capital Minority
Zhejiang Xianju Pharmaceutical Company Corporation Majority
To view Cuize Medicine’s complete investors history, request access »

Cuize Medicine FAQs

  • When was Cuize Medicine founded?

    Cuize Medicine was founded in 2019.

  • Where is Cuize Medicine headquartered?

    Cuize Medicine is headquartered in Hangzhou, China.

  • What industry is Cuize Medicine in?

    Cuize Medicine’s primary industry is Drug Discovery.

  • Is Cuize Medicine a private or public company?

    Cuize Medicine is a Private company.

  • What is the current valuation of Cuize Medicine?

    The current valuation of Cuize Medicine is .

  • What is Cuize Medicine’s current revenue?

    The current revenue for Cuize Medicine is .

  • How much funding has Cuize Medicine raised over time?

    Cuize Medicine has raised $12.6M.

  • Who are Cuize Medicine’s investors?

    Jiangguo Investment Management, Goldport Capital, and Zhejiang Xianju Pharmaceutical Company have invested in Cuize Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process